Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
ACCESS Newswire Q4 2025 Earnings Call - Subscription Pivot and Product-Led ARR Lift
ACCESS Newswire closed 2025 as a leaner, subscription-first company, delivering flat top-line but clear product momentum. Q4 revenue was $5.8 million, gross margin held at 77%, adjusted EBITDA remaine...
- Q4 revenue was $5.8 million, essentially flat sequentially and roughly flat year-over-year; full year 2025 revenue was $22.6 million, down about 2% from 2024.
- Gross margin improved to 77% in Q4 and for the full year, up from 75%/76% in the comparable 2024 periods, attributed to headcount efficiencies and fixed-cost leverage, partially offset by higher distribution spend.
- Adjusted EBITDA for Q4 was $881,000 (15% of revenue), roughly flat year-over-year; full-year adjusted EBITDA rose to $3.2 million or 14% of revenue, showing margin progress despite flat revenue.
- +12 more takeaways
NeurAxis Q4 2025 Earnings Call - CPT Code Flip, Payer Coverage Remains the Gatekeeper for IB-Stim Growth
NeurAxis framed Q4 and early 2026 as the moment the IB-Stim commercialization story moves from access creation to execution. A Category I CPT code effective January 1, 2026, plus new payer wins and a ...
- Category I CPT code for IB-Stim became effective January 1, 2026, shifting the company from access creation to commercial execution.
- NeurAxis added roughly 45 million covered lives via a major national insurer policy in December 2025, bringing total covered lives above 100 million for PENFS/IB-Stim.
- Payers do not provide coverage based solely on the CPT code, written medical policy coverage remains essential to reimbursement and volume.
- +16 more takeaways
Taysha Gene Therapies Full Year 2025 Earnings Call - FDA alignment and REVEAL pivotal launch set a possible 6-month pathway to BLA
Taysha presented a tightly choreographed advance toward registration for TSHA-102, anchored by FDA written alignment on trial design, CMC comparability, and a 6-month interim analysis for the REVEAL p...
- Taysha initiated the REVEAL pivotal trial in Q4 2025 and has dosed multiple patients, with company guidance to complete pivotal and ASPIRE dosing in Q2 2026.
- FDA provided written alignment on the REVEAL pivotal and ASPIRE trial designs, including acceptance of a 6-month interim analysis for the REVEAL pivotal trial.
- TSHA-102 has Breakthrough Therapy designation from the FDA, granted in September 2025.
- +12 more takeaways
Chicago Atlantic BDC, Inc. Q4 2025 Earnings Call - High-yield, low-leverage cannabis-focused BDC signals readiness while markets fret about private credit
Chicago Atlantic reported Q4 2025 NII of $0.36 per share and $1.45 for the year, underscoring a high-yield, low-leverage strategy centered on senior secured debt to largely cannabis and lower middle m...
- Q4 2025 net investment income was $0.36 per share, and $1.45 for the full year.
- Management cites a yield to book value of 2.7% for Q4 and 11% for the full year as evidence of the business model.
- Gross weighted average yield on debt investments was 15.8%, versus the average public BDC yield of 10.8% cited by management.
- +15 more takeaways
Datavault AI Q4 2025 Earnings Call - Reiterates $200M 2026 Revenue Target as NYIAX, IBM and Fiserv Fuel Tokenization Push
Datavault AI closed 2025 claiming a turning point. Management reported the company’s first GAAP profitable quarter with adjusted EBITDA north of $8 million, pared down debt and more than $115 million ...
- Company reported its first ever profitable GAAP quarter in Q4 2025, with adjusted EBITDA exceeding $8 million.
- Management said it substantially eliminated debt and finished the year with over $115 million in working capital.
- Datavault reiterated full-year 2026 revenue guidance of $200 million, expecting sequential growth each quarter and a majority of revenue weighted to H2 2026.
- +14 more takeaways
Movado Group, Inc. Fourth Quarter 2026 Earnings Call - Returned to growth, but tariffs shave roughly 150 basis points from margins
Movado closed fiscal 2026 by returning to growth after a tough prior year, with revenue up 2.7% to $671.3 million and adjusted operating income rising 28.7% to $34.8 million. Momentum accelerated into...
- Revenue returned to growth in fiscal 2026, up 2.7% year over year to $671.3 million; Q4 sales rose 5.6% to $191.6 million.
- Adjusted operating income jumped 28.7% for the year to $34.8 million, and Q4 adjusted operating income grew 6.2% to $14.4 million.
- Gross margin held nearly flat at about 54.1% to 54.2% despite external pressures, helped by favorable channel and product mix and operating leverage.
- +12 more takeaways
Lands’ End Q4 and Fiscal 2025 Earnings Call - $300M WHP IP JV to Eliminate Term Loan, Pivot to Licensing-Led Growth
Lands’ End closed fiscal 2025 with visible operational momentum and a balance sheet reset engineered through a strategic IP joint venture with WHP Global. Q4 wide-based strength drove 5% comp growth a...
- Q4 total revenue was $462 million, up 5% year over year, with GMV growing mid-single digits.
- Comparable sales rose 5% in Q4, driven by owned, licensed, and marketplace channels.
- FY adjusted EBITDA reached $102 million, a 10% increase versus prior year; Q4 adjusted EBITDA was $47 million, up 9%.
- +17 more takeaways
SOLV Energy Q4 2025 Earnings Call - $8B Safe-Harbored Backlog Fuels Aggressive 2026 Revenue Guide
SOLV Energy closed 2025 with record top and bottom line results and an $8 billion backlog that management says is fully safe-harbored. The company reported $2.49 billion of revenue and $342 million of...
- Record 2025 performance: revenue of $2.49 billion, up 35% year-over-year, and adjusted EBITDA of $342 million, more than double 2024.
- Q4 2025 revenue was $794 million, an 80% year-over-year increase, with realized gross profit of $144 million in the quarter.
- Backlog as of December 31, 2025 exceeded $8 billion, an 87% increase year-over-year, and management says 100% of backlog is safe-harbored.
- +12 more takeaways
Signet Jewelers Fiscal Q4 2026 Earnings Call - Delivered at high end of guidance amid tariffs and record gold, pivots to sharpen brand growth
Signet closed fiscal 2026 by delivering adjusted operating income and EPS at or above the high end of guidance despite unprecedented tariff pressure, record gold costs, and a cautious consumer, while ...
- Delivered at or above the high end of fiscal 2026 adjusted operating income and EPS guidance despite record gold costs and unprecedented tariffs.
- Free cash flow increased roughly 20% year over year to about $525 million, driven by higher earnings, lower cash taxes, and working capital efficiency.
- Management will sharpen Grow Brand Love in year two, focusing on Kay, Zales, Jared and three other engines to drive core growth and then expand adjacencies.
- +12 more takeaways
EquipmentShare Q4 and Full Year 2025 Earnings Call - Tech-Enabled Organic Growth Drives 34% Rental Revenue Gain and 54% Mature Site Margin
EquipmentShare reported a banner 2025, powered by organic expansion and its T3 tech stack. Rental revenue rose 34% to $2.7 billion, mature site adjusted EBITDA margin held at 54%, and adjusted core EB...
- Rental segment revenue was $2.7 billion in 2025, up 34% year-over-year.
- Added 95 rental locations in 2025, bringing the total to 385 locations at year-end.
- Adjusted core EBITDA was $1.7 billion, up 32% year-over-year.
- +16 more takeaways